Contravisory Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,644
| Closed | -$662K | – | 459 |
|
|
2024
Q4 | $662K | Sell |
1,644
-15
| -0.9% | -$6.04K | 0.14% | 97 |
|
|
2024
Q3 | $772K | Buy |
1,659
+192
| +13% | +$89.3K | 0.17% | 86 |
|
|
2024
Q2 | $688K | Sell |
1,467
-62
| -4% | -$29.1K | 0.15% | 86 |
|
|
2024
Q1 | $639K | Sell |
1,529
-30
| -2% | -$12.5K | 0.14% | 92 |
|
|
2023
Q4 | $634K | Buy |
1,559
+365
| +31% | +$149K | 0.16% | 85 |
|
|
2023
Q3 | $415K | Sell |
1,194
-42
| -3% | -$14.6K | 0.12% | 118 |
|
|
2023
Q2 | $435K | Buy |
+1,236
| New | +$435K | 0.12% | 127 |
|
|
2018
Q1 | – | Sell |
-30
| Closed | -$4K | – | 455 |
|
|
2017
Q4 | $4K | Sell |
30
-6
| -17% | -$800 | ﹤0.01% | 306 |
|
|
2017
Q3 | $5K | Buy |
+36
| New | +$5K | ﹤0.01% | 296 |
|
|
2016
Q1 | – | Sell |
-65
| Closed | -$8K | – | 235 |
|
|
2015
Q4 | $8K | Hold |
65
| – | – | ﹤0.01% | 131 |
|
|
2015
Q3 | $7K | Hold |
65
| – | – | ﹤0.01% | 142 |
|
|
2015
Q2 | $8K | Hold |
65
| – | – | ﹤0.01% | 157 |
|
|
2015
Q1 | $8K | Hold |
65
| – | – | ﹤0.01% | 132 |
|
|
2014
Q4 | $8K | Hold |
65
| – | – | ﹤0.01% | 134 |
|
|
2014
Q3 | $7K | Sell |
65
-45
| -41% | -$4.85K | ﹤0.01% | 125 |
|
|
2014
Q2 | $10K | Hold |
110
| – | – | ﹤0.01% | 114 |
|
|
2014
Q1 | $8K | Hold |
110
| – | – | ﹤0.01% | 132 |
|
|
2013
Q4 | $8K | Hold |
110
| – | – | ﹤0.01% | 107 |
|
|
2013
Q3 | $8K | Hold |
110
| – | – | ﹤0.01% | 100 |
|
|
2013
Q2 | $9K | Buy |
+110
| New | +$9K | ﹤0.01% | 108 |
|